Primary neuroendocrine carcinoma of the breast with leptomeninges metastasis: A case report and literature review

J Int Med Res. 2022 Sep;50(9):3000605221118505. doi: 10.1177/03000605221118505.

Abstract

Primary neuroendocrine carcinoma of the breast (NECB) is a rare tumour with an incident rate of 0.3-0.5%. The most common metastatic sites of NECB are liver, bones, lung, pancreas, soft tissues and brain, while leptomeninges metastasis (LM) is reported rarely. This current case report describes a 50-year-old female patient with NECB and LM whose overall survival was 2 months. The report also presents the current literature regarding the knowledge of this unusual tumour and metastatic type. The current patient was diagnosed with NECB with right cerebellar metastasis, followed by LM. She underwent modified radical mastectomy of the left breast, left whole breast radiation therapy and incomplete adjuvant chemotherapy until the metastasis occurred. Whole-brain radiation therapy and a first-line salvage regimen of etoposide and cis-platinum were then undertaken. The patient died 2 months after their LM diagnosis. Primary NECB with LM is sporadic, devoid of effective treatment and associated with a poor prognosis. Consequently, it is vitally important to identify LM in order to achieve longer patient survival.

Keywords: Breast cancer; case report; leptomeninges metastasis; neuroendocrine carcinoma of the breast; review.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Brain Neoplasms* / surgery
  • Breast Neoplasms* / pathology
  • Carcinoma, Neuroendocrine* / pathology
  • Carcinoma, Neuroendocrine* / therapy
  • Cranial Irradiation
  • Female
  • Humans
  • Mastectomy
  • Middle Aged